首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   186660篇
  免费   1686篇
  国内免费   435篇
化学   79004篇
晶体学   2820篇
力学   11011篇
综合类   8篇
数学   32097篇
物理学   63841篇
  2022年   945篇
  2021年   1046篇
  2020年   872篇
  2019年   848篇
  2018年   10402篇
  2017年   11271篇
  2016年   5891篇
  2015年   2150篇
  2014年   1923篇
  2013年   3986篇
  2012年   8524篇
  2011年   18037篇
  2010年   10958篇
  2009年   10978篇
  2008年   15586篇
  2007年   18975篇
  2006年   4001篇
  2005年   10747篇
  2004年   6729篇
  2003年   6233篇
  2002年   3959篇
  2001年   3595篇
  2000年   2878篇
  1999年   1981篇
  1998年   1353篇
  1997年   1286篇
  1996年   1368篇
  1995年   1073篇
  1994年   995篇
  1993年   905篇
  1992年   1179篇
  1991年   1149篇
  1990年   1044篇
  1989年   933篇
  1988年   901篇
  1987年   956篇
  1986年   791篇
  1985年   1051篇
  1984年   993篇
  1983年   713篇
  1982年   718篇
  1981年   691篇
  1980年   630篇
  1979年   778篇
  1978年   816篇
  1977年   723篇
  1976年   687篇
  1975年   574篇
  1974年   613篇
  1973年   583篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Nonperturbative nolocal structure of QCD vacuum is well described by instanton model. Specific helicity and flavor structure of zero modes of quarks, in instanton field allows simultaneously to explain some important features of low-and high-energy hadron phenomemology. The basic characteristics of hadron spectrum, partonic sum rules, heavyquark potential etc within the instanton liquid model are briefly discussed.  相似文献   
73.
Lanosterol derivatives with a functional group at C-32 have been synthesized from 3 beta-acetoxylanostan-7 alpha-ol. The key reaction of the synthesis is the hypoiodite reaction of 3 beta-acetoxylanostan-7 alpha-ol. In vitro antitumor activity testing of the lanosterol derivatives revealed that 3 beta-hydroxylanost-7-en-32-oic acid has antineoplastic activity.  相似文献   
74.
This paper presents an alternative to the beta continuous probability distribution for risk analysis. Particular attention has been given to two major applications of distributions, namely project management risk and critical path analysis (PERT). In conjunction with the beta, the triangular and normal distributions are frequently employed in order to give sufficient robustness to risk analysis. The beta distribution, as used in PERT, has a major theoretical implementation flaw. The new distribution was developed to give a possible alternative method of assessing risk. It is shown that the requirement to estimate the most pessimistic variate may be replaced by the probability to exceed the mode. Proposals for other simplifications in risk analysis are discussed. Practical means to validate the most appropriate distributions for risk analysis are outlined, and a cost-data case study is included.  相似文献   
75.
The spontaneous magnetization of the Ising model on a 4–8 lattice with six different coupling constants and two different magnetic moments is studied. A formula for the spontaneous magnetization is proposed. The result agrees with the exact low-temperature series expansions up to the 12th order.  相似文献   
76.
In this paper we discuss an initial-boundary value problem for a stochastic nonlinear equation arising in one-dimensional viscoelasticity. We propose to use a new direct method to obtain a solution. This method is expected to be applicable to a broad class of nonlinear stochastic partial differential equations.

  相似文献   

77.
Formalization for problems of multicriteria decision making under uncertainty is constructed in terms of guaranteed and weak estimates. A relevant definition of the vector maximinimax value is given. Parameterization and approximation of maximum, minimax, and maximinimax values based on the inverse logical convolution are suggested. An application for multicommodity networks is considered. Received: December 13, 2000 / Accepted: August 21, 2001?Published online May 8, 2002  相似文献   
78.
N-Terminal tripeptide analogs of fibrin alpha-chain were synthesized and their inhibitory effect on fibrinogen/thrombin clotting was examined. A new water-soluble active ester, 3-pyridinium ester, was used for the synthesis. Among the synthetic peptides, H-Gly-Pro-Arg-hexamethyleneimine exhibited the highest inhibitory effect on fibrinogen-thrombin clotting.  相似文献   
79.
The mode of action of the anti-complementary acidic heteroglycans, AAF-IIb-2 and IIb-3 which consisted of rhamnogalacturonan core and arabinogalactan moieties, purified from the leaves of Artemisia princeps PAMP (Japanese name = Gaiyo) were investigated. The anti-complementary activities of AAF-IIb-2 and IIb-3 were reduced partially in the absence of Ca2+ ions. A marked consumption of C4 was observed to have occurred when serum was incubated with both polysaccharides in the presence of Ca2+ ions. AAF-IIb-2 showed more potent C4 consumption than IIb-3. After the incubation of the serum with AAF-IIb-2 in the absence of Ca2+ ions, a cleavage of C3 in the serum was detected by immunoelectrophoresis. AAF-IIb-2 showed more significant consumption of the complement than IIb-3 when rabbit erythrocytes were used in the assay system in the absence of Ca2+ ions. These results indicate that AAF-IIb-2 activates the complement via both the alternative and classical pathways, whereas IIb-3 mainly activates the complement via the classical pathway. The absorption of serum with Protein A-Sepharose results in a decrease of the activity of AAF-IIb-2 and IIb-3. However, the decrease of the activity was restored by the replacement of the immunoglobulin G (IgG) fraction after its recovery from the Protein A-Sepharose. These results suggest that IgG dependent mechanisms are both involved in the anti-complementary activity of AAF-IIb-2 and IIb-3.  相似文献   
80.
Hilbert重级数定理的一个改进   总被引:15,自引:3,他引:12       下载免费PDF全文
The object of this note is to prove the followingTheorem Let{a_n}and{b_n}be sequences of real numbers such that0<∑∑a_n~2<+∞and0<∑b_n~2<+∞.Then we have the inequalitysum from m=1 to∞sum from n=1 to∞a_mb_n/m+n<{sum from n=1 to∞(π-θ/n~(1/2)a_n~2}~1/2{sum from n=1 to∞(π-θ/n~(1/2)b_n~2}~1/2 (1)whereθ=3/2~(1/2)-1=1.121320343.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号